Oxymorphone Hydrochloride
Product Images NDC 63304-221

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 63304-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

5 mg (5mgcarton)

5 mg (5mgcarton)
This appears to be a mixed text with no clear context or meaning. It is not available.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
FDA Label Image

Structure (Image 01)

Structure (Image 01)
FDA Label Image

40 mg (Image 02)

40 mg (Image 02)
FDA Label Image

7.5 mg (Image 03)

7.5 mg (Image 03)
FDA Label Image

10 mg (Image 04)

10 mg (Image 04)
This text appears to be a medication label and prescription information for Oxymorphone HCI extended-release tablets. It includes dosage instructions, manufacturer information, and prescription details.*
FDA Label Image

15 mg (Image 05)

15 mg (Image 05)
FDA Label Image

20 mg (Image 06)

20 mg (Image 06)
FDA Label Image

30 mg (Image 07)

30 mg (Image 07)
Twice-A-Day (every 12 hours) Oxymorphone HCI extended-release tablets manufactured by Riabary Pharmaceuticals in Jackson, AL. Other text is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.